Skip to search
Skip to main content
Back to Search
Start Over
Impact of Prior Jak-Inhibitor Therapy With Ruxolitinib on Outcome After Allogeneic Stem Cell Transplantation For Myelofibrosis. A Large EBMT-CMWP Study
Authors :
Kroeger, Nicolaus Sbianchi, Giulia Sirait, Tiarlan Beelen, Dietrich Passweg, Jakob Robin, Marie Vrhovac, Radovan Helbig, Grzegor Sockel, Katja Conneally, Eibhlin Rubio, Marie Therese Beguin, Yves Finke, Juergen Bernasconi, Paolo Morozova, Elena Clausen, Johannes Dem Borne, Peter Nicolaas Schaap Schroyens, Wilfried Patriarca, Francesca Di Renzo, Nicola Yegin, Zeynep Arzu Hayden, Patrick Mclornan, Donal Yakoub-Agha, Ibrahim
Source :
Web of Science
Publication Year :
2021
Details
Language :
English
Database :
OpenAIRE
Journal :
Web of Science
Accession number :
edsair.dedup.wf.001..74f1ef5a88a4a9d1ec084db4c6a6bc1d